For the quarter ending 2025-12-31, MODD had -$2,379K decrease in cash & cash equivalents over the period. -$8,377K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Other | - | - | 0 |
| Net loss | -7,360 | -7,790 | -6,702 |
| Stock-based compensation expense | 534 | 813 | 724 |
| Depreciation and amortization | 430 | 391 | 410 |
| Change in fair value of warrant liabilities | 129 | - | - |
| Shares issued for services | 3 | 2 | 2 |
| Prepaid expenses and other assets | -97 | -138 | 338 |
| Lease right-of-use asset | 101 | 99 | 98 |
| Accounts payable and accrued expenses | -983 | 1,040 | 536 |
| Lease liabilities | -106 | -104 | -102 |
| Net cash used in operating activities | -7,155 | -5,411 | -5,372 |
| Purchases of property and equipment | 1,222 | 771 | 934 |
| Net cash used in investing activities | -1,222 | -771 | -934 |
| Proceeds from at-the-market sales of common stock, net | 1,902 | 732 | - |
| Proceeds from exercise of common stock purchase warrants | 0 | 0 | 5 |
| Proceeds from public offering of common stock and warrants, net | 4,828 | - | - |
| Proceeds from at-the-market sale of common stock, net | - | - | 728 |
| Proceeds from warrant inducement offering, net | 0 | 3,972 | - |
| Net cash provided by financing activities | 5,998 | 3,976 | 733 |
| Net decrease in cash and cash equivalents | -2,379 | -2,206 | -5,573 |
| Cash and cash equivalents at beginning of period | 5,316 | 13,095 | - |
| Cash and cash equivalents at end of period | 2,937 | 5,316 | - |
Modular Medical, Inc. (MODD)
Modular Medical, Inc. (MODD)